Search
Now showing items 1-10 of 15
Programa de coordinación en la transición asistencial para la mejora de la farmacoterapia entre un Servicio de Urgencias y un Centro Sociosanitario
(Organización de Farmacéuticos Ibero-Latinoamericanos (OFIL), 2022)
Objetivos: Describir un programa de colaboración entre farmacéuticos de un Servicio de Urgencias y un Centro sociosanitario, así como evaluar su impacto sobre la frecuencia de reconsulta al Servicio de ...
Fine-tuning formulation and biological interaction of doxorubicin-loaded polymeric nanoparticles via electrolyte concentration modulationFine-tuning formulation and biological interaction of doxorubicin-loaded polymeric nanoparticles via electrolyte concentration modulation
(Elsevier, 2023-09)
Doxorubicin (DOX) is amongst the most widely used chemotherapeutic drugs against various cancers. However,
its controlled biodistribution to the tumor site at the required pharmacokinetics profile ...
Pharmacogenetics of antipsychotics: clinical utility and implementationPharmacogenetics of antipsychotics: clinical utility and implementation
(Elsevier, 2020-12)
Decades of research have produced extensive evidence of the contribution of genetic factors to
the efficacy and toxicity of antipsychotics. Numerous genetic variants in genes controlling drug
availability ...
Pharmacogenetic influences on the response to pharmacological treatment in autism spectrum disorders
(OAE Publishing, 2021-07)
Aim: About a third of patients with autism spectrum disorder (ASD) receive pharmacological treatment for comorbid symptoms. However, 30%-50% do not respond adequately and/or present severe and long-lasting ...
Pharmacogenetic interventions improve the clinical outcome of treatment-resistant autistic spectrum disorder sufferers
(MDPI, 2022-05)
BACKGROUND: Autistic spectrum disorders (ASD) are severe neurodevelopmental alterations characterised by deficits in social communication and repetitive and restricted behaviours. About a third of ...
Parental genetically predicted liability for coronary heart disease and risk of adverse pregnancy outcomes: a cohort study
(BioMed Central, 2024-01)
Background
Adverse pregnancy outcomes (APO) may unmask or exacerbate a woman’s underlying risk for coronary heart disease (CHD). We estimated associations of maternal and paternal genetically predicted ...
Placental efflux transporters and antiseizure or antidepressant medication use impact birth weight in MoBa cohort
(Cell Press, 2024-03)
Low birth weight raises neonatal risks and lifelong health issues and is linked to maternal medication use during pregnancy. We examined data from the Norwegian Mother, Father, and Child Cohort Study ...
Optimització de la resistència a antiinfecciosos en la pràctica clínica
(Col·legi de Farmacèutics de Barcelona, 2021)
Avaluar la idoneïtat de la prescripció d’antibacterians en la gestió clínica de les infeccions bacterianes en un establiment sanitari
privat amb una alta rotació de facultatius, per tal de contribuir ...
Anticholinergic burden and safety outcomes in older patients with chronic hepatitis C: A retrospective cohort study
(MDPI, 2020-05)
Aim: Older patients with chronic hepatitis C infection starting direct-acting antivirals (DAAs) are frequently prescribed multiple medications that may be categorized as inappropriate. Anticholinergic ...
CES1 and SLC6A2 genetic variants as predictors of response to methylphenidate in autism spectrum disorders
(Dove Medical Press, 2022-11)
Purpose
Autistic spectrum disorders (ASD) children and adolescents usually present comorbidities, with 40–70% of them affected by attention deficit hyperactivity disorders (ADHD). The first option of ...